Status:
RECRUITING
Clinical Explorative Optical Breast Investigations
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Lund University
Unilabs
Conditions:
Benign Breast Tumors
Malignant Breast Tumours
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study evaluates diffuse reflectance spectroscopy and photoacoustic imaging for differentiating healthy, benign, and malignant breast tissue by identifying their optical profiles.
Detailed Description
Breast cancer is the most prevalent cancers among women worldwide. Current diagnostic modalities have notable limitations. Mammography exposes patients to harmful ionising radiation whilst MRI often r...
Eligibility Criteria
Inclusion Criteria:
- solitary malignant or benign biopsy verified tumour > 1 cm
- understands written and oral Swedish
Exclusion Criteria:
- previous breast surgery
- has received neoadjuvant chemotherapy
- skin burns in on the chest
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06857669
Start Date
December 1 2020
End Date
May 30 2027
Last Update
March 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skane University Hospital
Malmo, Sweden, 20502